An expression vector was constructed that carries part of the human BK papovavirus with 0.5 kilobases of (2'-5')oligoadenylate (2.5A) synthetase cDNA inserted in inverted orientation downstream from the virion proteins (VP) promoter and the neomycin-resistance gene neo under the control of a simian virus 40 promoter. Cells transfected with this vector and selected for resistance to the neomycin derivative G418 synthesized RNA complementary to 2-5A synthetase mRNA. These cells lacked 2-5A synthetase activity, and the enzyme was not inducible by interferon. In contrast, 2-5A synthetase was induced in cells transfected with a control vector without the cDNA insert. Such cells were protected by interferon from RNA viruses, whereas cells lacking 2-5A synthetase were not protected from encephalomyocarditis virus, vesicular stomatitis virus, and Sindbis virus but were fully protected from influenza virus. These findings show that a high level of 2-5A synthetase is required for interferon-induced protection from the cytoplasmic RNA viruses tested.
Treatment of human and murine cells with interferons
induces transcription of several mRNAs. Corresponding cDNAs have been cloned and sequenced (1) (2) (3) (4) (5) . The IFNinduced mRNAs code for proteins that can be detected by two-dimensional gel electrophoresis (6) , but the biological role of many of these proteins remains unknown. Two enzymatic activities are elevated in IFN-treated cells: (2'-5')oligoadenylate (2-5A) synthetase and a protein kinase (PKdS). When activated by double-stranded RNA, the synthetase polymerizes ATP into 2-SA, which activates a nuclease designated RNase L, and the kinase phosphorylates the a subunit of initiation factor eIF-2 (7) . Other IFN-induced proteins identified with specific antisera or by sequencing the corresponding cDNAs are class I and II histocompatibility antigens (8) , metallothionein II, and thymosin ,4 (9) .
IFN-treated cells are protected against a variety of viral infections, but the role of individual IFN-induced proteins in the defense against specific viruses is not firmly established, with the exception of the Mx protein, which inhibits the nuclear synthesis of influenza virus mRNA (10) . The 2-5A synthetase and PKds may block the replication ofcytoplasmic RNA viruses (11) , but little is known about the role of other IFN-induced proteins in the antiviral state or in the inhibition of cell growth by IFN. Mutants defective in the synthesis of IFN-induced proteins, such as murine cells with a deletion in the Mx gene (12) , have been useful in studying the function of antiviral proteins. Human fibroblast variants lacking PKdS activity have been described (13) . The d1331 mutant of adenovirus, which does not produce a small virus-associated RNA, can grow with nearly normal kinetics in these cells (14) . This and other observations show that the small RNA antagonizes the antiviral activity of IFN by preventing activation of PKd, (15, 16) . Murine cell variants defective in the induction of 2-5A synthetase have been reported (17) . IFN does not inhibit replication of vesicular stomatitis virus and mengovirus in these cells, but it is not known whether it induces the PKdS It is often difficult to establish whether cell variants are defective in the synthesis of a single IFN-induced protein.
Alternatively, synthesis of a specific protein may be inhibited by complementary "antisense" RNA. The inhibition of mRNA translation by antisense RNA was discovered in bacterial systems (18) (19) (20) . In animal cells, thymidine kinase is inhibited by expression of RNA complementary to the mRNA for this enzyme (21) . Antisense RNA anneals to mRNA or to its nuclear precursors to form double-stranded structures, which fail to enter the cytoplasm (22) . The antisense RNA can be relatively small, since a 52-base RNA complementary to the 5' leader sequence of an mRNA inhibits its expression (23) . This inhibition requires a high level of antisense RNA, which can be obtained by driving its transcription with an inducible promoter (23) or by selecting cells with a high copy number of the antisense RNA transcription unit (22) . By expressing antisense RNA, phenocopies of mutants were obtained in Drosophila (24) and Dictyostelium (25) . In the present investigation, we utilized the episomal BK virus vector described by Milanesi et al. (26) to obtain constitutive expression of antisense RNA for 2-5A synthetase. Loss of this enzymatic activity allowed us to define its role in the defense against specific viruses.
MATERIALS AND METHODS
Vectors. The expression vector pDB-E1 was assembled by combining elements from three plasmids in a series of steps (Fig. 1 ). The 2-5A synthetase cDNA was excised from pBR-E1 (3) with Pst I and inserted (step a) into the polylinker of pGEM-1 (Promega Biotec, Madison, WI). The orientation of this insert was determined by digestion with EcoRI (b), because of a convenient internal EcoRI site in the cDNA. The neo gene excised from pSV-neo (27) with Sal I and BamHI was inserted (c) into the polylinker of pGEM-El. pGEM-Elneo and pGEM-BK were digested with EcoRI and ligated (f). pGEM-BK was constructed by inserting the large EcoRI fragment of pBK TK-1 (26) into the pGEM-1 polylinker (d) and was modified by partial digestion with EcoRI followed by elimination of one EcoRI site by filling in with T4 DNA polymerase (e). Escherichia coli HB101 transfected with pDB-E1 was selected for resistance to both ampicillin and neomycin (27) . The orientation of the E1-neo insert in cloned plasmids was determined by digestion with Sma I. The pDB-E1 vector contained 0.5 kilobase pairs of 2-5A synthetase cDNA inserted downstream from the virion proteins (VP) promoter of BK virus in an antisense orientation. The pDB-0 vector without this insert was constructed in a similar way. The neo gene was inserted into the polylinker of pGEM-1 to construct pGEM-neo, as described above. The large EcoRI fragment of pBK TK-1 was inserted into the EcoRI site of pGEM-neo to obtain pDB-0.
Cell Transfection and Selection. Human osteosarcoma (HOS) cells (28) were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum to form confluent monolayers in 25-cm2 flasks. The cells were washed twice with medium minus serum before addition of 1-3 ,ug of vector DNA in 1 ml of phosphate-buffered saline (0.14 M NaCl/4 mM KCI/10 mM phosphate, pH 7.4) and 0.08 ml of 1 M CaCl2 in 10 mM Hepes buffer (pH 7.4). After 20 min, 9 ml of complete medium was added for 5 hr. The cells were washed twice with 5 mM EDTA in phosphate-buffered saline before addition of fresh medium containing G418 (27) at 0.4 mg/ml. This medium was changed daily for 4 days and then once a week. Small colonies of G418-resistant cells were seen after 1 week. These cells were grown as mass cultures and retained resistance to G418 even after passage in nonselective medium (26) but were treated with this antibiotic every third passage. Vector DNA was extracted from these cells by the Hirt (29) procedure.
RNA Preparation and Analysis. The cells were homogenized in hypotonic buffer containing 40 pg of dextran sulfate per ml and were fractionated into a nuclear pellet and a cytoplasmic extract (30) . The nuclei were resuspended in 0.4 ml of the same buffer, boiled for 1 min, and centrifuged again. After phenol extraction of the supernatant and the cytoplasmic fraction, RNA was precipitated with ethanol and hybridized to a probe synthesized with T7 RNA polymerase from pGEM-E1 linearized with HindIll. This probe contained a 333-base sequence of 2-5A synthetase mRNA (3) and was labeled with [3H]UTP to 1.2 x 107 cpm/ptg. Synthesis of this probe, hybridization, and digestion with RNases A and T1 were carried out according to the instructions of the manu-facturer of pGEM-1 (Promega Biotec). The probe was purified by electrophoresis in 1.5% agarose gels; 106 cpm of purified probe were used for each reaction. RNase-resistant duplexes were extracted with phenol, precipitated with ethanol after addition of 5 ug of carrier tRNA, and analyzed by gel electrophoresis.
2-5A Synthetase and PK& Assays. The 2-SA synthetase was assayed as described (31) with 1 gg of poly(inosinic)-poly-(cytidylic) acid, 30 mM Mg(OAc)2, 10 mM ATP, and 1 liCi of [3H]ATP (1 Ci = 37 GBq) in 50-1l reaction mixtures incubated for 4 hr. The PKdS was assayed as described (32) .
Virus Assays. Cells seeded in multiwell cluster plates were treated for 18 hr with different concentrations of human recombinant IFN-aA obtained from Hoffmann-La Roche. The cells were infected with various viruses at a multiplicity sufficient to kill at least 90% of control untreated cells in 48 hr (33) . The cytopathic effect of virus infections was measured as described (34) . Reovirus (Dearing III) RNA synthesis was measured by labeling infected cells with [3H]uridine 15 min after the addition of 5 ,ug of actinomycin D per ml (35) .
RESULTS
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Multicopy Expression Vector. A shuttle expression vector containing parts of plasmids pBK TK-1 (26), pSV-neo (27) , and pBR-E1 (3) was assembled through the series of steps outlined in Fig. 1 . The cDNA of pBR-E1, which corresponds to the 3' end of different mRNAs coding for 2-SA synthetase (36) was inserted between the T7 and SP6 phage promoters of a pGEM-1 plasmid. This construct was joined to a fragment of pSV-neo containing the selectable neomycinresistance marker (neo gene) under the control of the simian virus 40 early promoter. A fragment of this pGEM-E1-neo plasmid, containing 0.5 kilobase pairs of cDNA and neo was then joined to a large fragment of pBK TK-1 containing the intact T/t gene and a truncated VP gene (26) . The cDNA was inserted downstream from the VP promoter in inverted orientation to obtain the pDB-E1 vector. The vector pDB-0, without inserted cDNA, was prepared in a similar way for control experiments. These vectors were selectable for resistance to ampicillin or neomycin in E. coli and to the neomycin derivative G418 in eukaryotic cells. Various lines of human cells were transfected with both vectors and incubated with G418. The best results were obtained with HOS cells (28) , which remained firmly attached as monolayers after transfection and were highly sensitive to G418. HOS cells transfected with pDB-E1 or pDB-0 and selected for G418 resistance were designated DB-E1 and DB-0, respectively. The vectors replicated episomally, since supercoiled DNA corresponding in size to pDB-E1 or pDB-0 could be recovered from transfected cells in the Hirt (29) supernatant (Fig. 2) . This DNA was visualized by ethidium bromide staining and the vector copy number was estimated by comparison with known amounts of pDB-0 DNA ( Fig. 2A) . From the quantity of vector DNA recovered, we calculated that at least 400 copies were present per cell. Approximately the same vector copy number was found in both DB-E1 and DB-0 cells, as shown by Southern blot analysis (Fig. 2B) .
The presence of antisense RNA in DB-E1 cells was demonstrated by hybridization of RNA extracted from nuclei and cytoplasm to an RNA probe containing 333 bases of 2-5A mRNA. RNase-resistant polynucleotides were analyzed by gel electrophoresis (Fig. 3) . A duplex of the expected size was obtained with both nuclear and cytoplasmic RNA, and a smaller duplex of about 160 base pairs was also seen. This duplex was possibly formed by partial cleavage of the A+U-rich region at 158-163 (3). From the amount of duplexes recovered and the specific activity of the RNA probe, we estimated that at least 104 molecules of antisense RNA were present per DB-E1 cell; 56% of this material was recovered in the nuclear RNA fraction. A similar analysis of RNA from DB-0 cells did not yield RNase-resistant duplexes.
Loss of 2-5A Synthetase and Antiviral Activity. The enzymatic activity of 2-5A synthetase was measured in cytoplasmic extracts of DB-E1, DB-0, and HOS cells before and after treatment with IFN-aA. The activity was increased about 35-fold over the basal level in IFN-treated HOS and DB-0 cells but was not increased in DB-E1 cells ( Table 1) . Furthermore, the 2-5A synthetase activity in DB-E1 cells was below the limit of detection of our assay. 2-5A synthetase activity is elevated in cells in stationary phase (38, 39) . Therefore, we measured this enzymatic activity in extracts of confluent cells and found that it was increased about 4-fold in HOS and DB-0 cells, but it was barely increased up to the level of detection of our assay in DB-E1 cells ( Table 1 ). 2-5A synthetase has been detected in both cytoplasm and nuclei of human cells (37) , and different mRNAs code for these enzymatic activities in murine cells (40) . Nuclei from both lines of transfected cells were isolated and the 2-5A synthetase was assayed as previously described (37) . DB-0 nuclei synthesized significant amounts of 2-5A, and treatment with IFN-aA increased the level of nuclear 2-5SA synthetase activity (Table 1 ). DB-E1 nuclei failed to synthesize detectable amounts of 2-5A, and IFN-aA did not increase the synthetase activity to a level detectable by our assay (Table  1 ). These results show that all IFN-induced or constitutive, cytoplasmic and nuclear 2-5A synthetase activities are lacking in cells expressing antisense RNA.
To establish whether only 2-SA synthetase was specifically lacking in DB-E1 cells, we assayed another IFN-inducible enzyme, PKd,. This kinase was detected by the phosphoryl- Subconfluent cultures in 175-cm2 flasks were either untreated or treated for 18 hr with 300 units of IFN-aA per ml. Confluent cultures were harvested 1 day after reaching saturation density. Cytoplasmic extracts and isolated nuclei were assayed for 2-SA synthetase as described (31, 37) . This activity is expressed in nmol of ATP polymerized into 2-SA per mg of cytoplasmic protein or per 10' nuclei, during a 1-hr incubation. ation of a Mr 70,000 polypeptide in IFN-treated DB-E1 cells, but not in untreated cells (Fig. 4) . Therefore, only 2-5A synthetase failed to be induced in these cells, which otherwise responded normally to IFN with an increase in PKd,.
The consequences of a lack of 2-5A synthetase activity on the resistance to viral infections was investigated by treating DB-E1 and DB-0 cells with a wide range of IFN concentrations and assaying the cytopathic effect of different RNA viruses (Fig. 5 ). DB-E1 cells were slightly protected against encephalomyocarditis virus (EMCV) only after treatment with >1000 units of IFN-aA per ml, whereas DB-0 cells were fully protected by 100 units per ml. No protection of DB-E1 cells against Sindbis virus and vesicular stomatitis virus Monolayers seeded in cluster plates were treated for 18 hr with the IFN-aA concentrations indicated and infected with encephalomyocarditis virus (EMCV), Sindbis virus, vesicular stomatitis virus (VSV), or influenza virus (Flu) as described in Materials and Methods. The cytopathic effect was measured by staining live cells (34) . The OD540 relative to uninfected control cells is shown. (VSV) was observed with 3000 units of IFN per ml, whereas DB-0 cells were protected by 3-10 units per ml. In contrast, both cell lines were effectively protected from influenza virus at similar IFN concentrations. Results identical to those of DB-0 cells were obtained with the parental HOS cells (data not shown). These findings showed that in DB-E1 cells, IFN elicited an antiviral state against influenza virus but not against the other viruses tested. Infection with reovirus did not result in a clear cytopathic effect in DB-0 or DB-E1 cells. Therefore, the antiviral activity against reovirus was measured by following the synthesis of viral RNA in infected cells (Fig. 6) . The time course of reovirus RNA synthesis was virtually identical in untreated DB-0 and DB-E1 cells. Reovirus replication was completely abolished in IFN-treated DB-0 cells, whereas it was delayed in IFN-treated DB-E1 cells (Fig. 6 ). This finding suggested that some protection against reovirus could be elicited by IFN in DB-E1 cells, but that the lack of 2-5A synthetase activity ultimately allowed viral RNA to be synthesized at almost the same rate as in untreated cells. These results showed that 2-5A synthetase plays an essential role in the protection elicited by IFN against specific RNA viruses.
DISCUSSION
Cells transfected with pDB-El or pDB-0 and selected for G418 resistance contain a similar and relatively high copy number of these episomal vectors. Transcription of 2-5A synthetase antisense RNA from the VP promoter of the pDB-El vector accounts for the loss of this enzymatic activity in IFN-treated and untreated DB-E1 cells. This loss is apparently responsible for the lack of protection of IFNtreated DB-E1 cells from infection by encephalomyocarditis virus, vesicular stomatitis virus, and Sindbis virus. These cells respond to IFN, as shown by the increase in PKYd and by the induction of resistance to influenza virus. This finding allows us to conclude that 2-5A synthetase is required for protection of DB-0 and HOS cells from all the other RNA .,
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viruses tested. The resistance to influenza virus is due to the Mx protein (12) , and 2-5A synthetase does not appear to play any role in the defense against this virus. Elevated 2-5A synthetase activity may not be sufficient for protection from some RNA viruses. This is suggested by the observation that PCC4 murine embryonal carcinoma cells, which are inducible for 2-5A synthetase but not for PKdS (41) , are protected by IFN from encephalomyocarditis virus and mengovirus but not from vesicular stomatitis virus and Sindbis virus (33) . However, the level of 2-5A synthetase induced by IFN in PCC4 cells is lower than that induced in murine L cells, which are well-protected by IFN from all these viruses (33) .
DB-E1 cells with inducible PKd, but no 2-5A synthetase are only partially protected from reovirus, as shown by the delayed synthesis of viral RNA. The PKMS is activated in IFN-treated cells infected with reovirus (42, 43) , and translation of reovirus mRNA is partially inhibited at the level of initiation (35) . Thus, it seems possible that the synthesis of viral proteins is at least in part inhibited in IFN-treated DB-E1 cells and that the amplification of viral RNA transcription is delayed for this reason.
Cells lacking 2-5A synthetase are perfectly viable, and it seems likely that this enzymatic activity does not perform any essential function in human cells outside of the antiviral state elicited by IFN. However, we cannot exclude that very small amounts of 2-5A synthetase, which are below the limit of detection of our assay, may be present in DB-E1 cells. These cells replicate at a faster rate than DB-O and parental HOS cells (data to be published elsewhere). Since the only obvious difference between DB-O and DB-E1 cells is that DB-E1 cells lack 2-5A synthetase activity, it is possible that this enzyme may be involved in regulation of cell proliferation.
The method developed to suppress the expression of 2-5A synthetase is generally applicable to other cell systems in order to produce phenocopies of mutants for nonessential constitutive and inducible genes. It may be useful in elucidating the function of IFN-induced proteins for which cloned cDNAs have been obtained (1-5) but no biological role has yet been identified.
